Editas Medicine (EDIT) Other Operating Expenses (2016 - 2020)
Editas Medicine (EDIT) posted quarterly Other Operating Expenses of $2000.0 for Q4 2020, up 100.0% year-over-year from $1000.0 in Q1 2020, and up 100.0% quarter-over-quarter from $1000.0 in Q4 2019.
Editas Medicine (EDIT) Other Operating Expenses (2016 - 2020) Analysis & Trends
Editas Medicine (EDIT) has reported Other Operating Expenses for 4 consecutive years, with $2000.0 the latest figure, recorded in Q4 2020.
- In Q4 2020, Other Operating Expenses rose 100.0% year-over-year to $2000.0; the TTM figure through Sep 2021 stood at $2000.0 (up 100.0% YoY), while the FY2016 annual figure was $40.5 million, changed N/A from the prior year.
- Other Operating Expenses climbed to $2000.0 in Q4 2020 per EDIT's latest filing, from $1000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $40.1 million in Q4 2017 and bottomed at $1000.0 in Q4 2019.
- Historically, Other Operating Expenses has averaged $12.6 million across 4 years, with a median of $5.2 million in 2016.
- Annual changes were most pronounced in 2017 — Other Operating Expenses soared 288.09% — and 2020, when it jumped 100.0%.
- Editas Medicine's Other Operating Expenses stood at $10.3 million in 2016, then jumped by 288.09% to $40.1 million in 2017, then slumped by 100.0% to $1000.0 in 2019, then surged by 100.0% to $2000.0 in 2020.
- Business Quant data shows EDIT's Other Operating Expenses at $2000.0 in Q4 2020, $1000.0 in Q4 2019, and $40.1 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Editas Medicine | 263.01 Mn | 116.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Dec 31, 2017 | 40.11 Mn |
| Dec 31, 2016 | 10.34 Mn |